Texas Biomedical Research Institute

Southwest Research, Texas Biomedical awarded $3.4M for Ebola countermeasure

Wednesday, June 8, 2016

Southwest Research Institute (SwRI) has announced a one-year, $3.4 million contract award from the Defense Threat Reduction Agency (DTRA) to combine two available medications and test the resulting combination drug therapy against the Ebola virus. SwRI is collaborating with Texas Biomedical Research Institute on this program. The award is a one-year contract with two additional option years.

[Read More]